| Mercury Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 538964 |
NSE Symbol : - |
P/E(TTM) : 21.46 |
|
ISIN Demat : INE947G01011 |
Div & Yield% : 0.40 |
EPS(TTM) : 40.95 |
|
Book Value(₹) : 464.65 |
Market Cap(₹Cr) : 105.46 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 19.01 | 18.14 | 20.66 | 19.57 | 18.19 | 16.68 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 19.01 | 18.14 | 20.66 | 19.57 | 18.19 | 16.68 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.79 | 0.18 | 0.18 | 0.53 | 0.21 | 0.15 |
| Total Income | 19.80 | 18.32 | 20.84 | 20.10 | 18.40 | 16.83 |
| Total Expenditure | 16.88 | 15.78 | 18.54 | 17.60 | 16.88 | 15.07 |
| PBIDT | 2.92 | 2.54 | 2.31 | 2.51 | 1.52 | 1.76 |
| Interest | 0.13 | 0.15 | 0.13 | 0.13 | 0.15 | 0.14 |
| PBDT | 2.79 | 2.39 | 2.18 | 2.38 | 1.37 | 1.62 |
| Depreciation | 0.86 | 0.84 | 0.73 | 0.74 | 0.71 | 0.70 |
| Tax | 0.57 | 0.48 | -0.11 | 0.69 | 0.37 | 0.40 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.29 | 0.10 | 0.45 | -0.24 | -0.22 | 0.18 |
| Reported Profit After Tax | 1.64 | 0.97 | 1.11 | 1.19 | 0.50 | 0.34 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.64 | 0.97 | 1.11 | 1.19 | 0.50 | 0.34 |
| EPS (Unit Curr.) | 13.69 | 8.06 | 9.25 | 9.94 | 4.17 | 2.85 |
| EPS (Adj) (Unit Curr.) | 13.69 | 8.06 | 9.25 | 9.94 | 4.17 | 2.85 |
| Calculated EPS (Unit Curr.) | 13.69 | 8.06 | 9.25 | 9.94 | 4.17 | 2.85 |
| Calculated EPS (Adj) (Unit Curr.) | 13.69 | 8.06 | 9.25 | 9.94 | 4.17 | 2.85 |
| Calculated EPS (Ann.) (Unit Curr.) | 54.78 | 32.25 | 37.01 | 39.76 | 16.68 | 11.38 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 54.78 | 32.25 | 37.01 | 39.76 | 16.68 | 11.38 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
| Reserve & Surplus | 54.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 15.36 | 14.00 | 11.18 | 12.83 | 8.36 | 10.55 |
| PBDTM(%) | 14.68 | 13.18 | 10.55 | 12.16 | 7.53 | 9.71 |
| PATM(%) | 8.63 | 5.35 | 5.37 | 6.08 | 2.75 | 2.04 |